Trials / Completed
CompletedNCT02967731
480 Biomedical Sinus Drug Depot
An Exploratory Safety Study of 480 Biomedical Sinus Drug Depot in Adult Subjects With Chronic Sinusitis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Lyra Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase I, exploratory safety study of the 480 Biomedical Mometasone Furoate Sinus Drug Depot in adult subjects with chronic sinusitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 480 Mometasone Furoate Sinus Drug Depot | Management of Chronic Sinusitis |
Timeline
- Start date
- 2017-06-06
- Primary completion
- 2017-12-19
- Completion
- 2018-05-18
- First posted
- 2016-11-18
- Last updated
- 2021-08-25
Locations
4 sites across 2 countries: Australia, New Zealand
Source: ClinicalTrials.gov record NCT02967731. Inclusion in this directory is not an endorsement.